Company intelligence / Profile preview

Unichem Laboratories Ltd

Mumbai, Maharashtra, Indiaunichemlabs.com ↗

Ownership: Public · UNICHEMLAB
Employees: ~3100
Development stage: Commercial

Overview

Unichem Laboratories is a well-established pharmaceutical company with multiple ANDA approvals from the USFDA for various products. The company has received international accreditations for its manufacturing facilities.

Therapeutic areas: EndocrinologyImmunologyPsychiatryGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculesActive Pharmaceutical Ingredients (APIs)Formulations
Industry: Biotech

Drug pipeline

6 assets

doxazosin

Commercial

Indications: Hypertension

5 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with multinational pharmaceutical organizations and generic companies

Financials

Market cap: $531.7B
Total revenue: $400.3B

Beyond the preview

Go deeper on Unichem Laboratories Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unichem Laboratories Ltd.

Explore the full profile